With the July FOMC minutes about to shed more light on how close the Federal Reserve might be to another rate hike, interest rate expectations are back in the spotlight and so are the growth stocks most exposed to those shifting signals. For investors who care about how financing costs and discount rates may affect future growth stories, this is a moment to pay attention. This article walks through three U.S. interest rate sensitive growth stocks from our screener that appear positively exposed to the latest mix of softer inflation, a surprise loss of 23,000 jobs in July and a Fed that is now offering less forward guidance.
The stocks highlighted below are just a starting sample from this idea. The full screen surfaced 23 more U.S. interest rate sensitive growth companies with equally compelling narratives that are not covered in this article. To identify and analyze the highest conviction opportunities straight away, head into the U.S. Interest-Rate-Sensitive Growth Stocks screener.
Cellebrite DI is a digital investigations software company whose subscription based tools help law enforcement and corporations access, analyze and manage digital evidence. This fits the screener’s focus on higher growth, rate sensitive software stocks. The business currently reports all of its roughly US$514 million in revenue from internet software and services and has a market cap of about US$2.8b. That combination of software scale and growth expectations means interest rate shifts can have a meaningful impact on how the stock is valued.
For investors watching how lower rate expectations might support higher growth multiples, Cellebrite DI offers a mix of recurring SaaS revenue, AI driven analytics and exposure to rising digital crime and security needs. The company is leaning into cloud and AI, but is also dealing with timing issues around large government contracts and a premium valuation that leaves little room for disappointment. For those who want a closer look at how those moving parts interact with Fed policy and market sentiment, Cellebrite’s story may be worth following beyond the headlines.
Cellebrite DI’s mix of recurring SaaS revenue and premium expectations can look compelling when rate pressures ease, but the real story sits in the 4 key rewards and 2 important warning signs
Cellebrite DI and the two other growth stocks in this article all came from a single screener, but the real edge comes when you design your own filters. Use our customisable Screener to mix metrics like valuation, growth and balance sheet strength, or tap into the ready made Investing Ideas for curated starting points.
Five9 is a cloud based contact center software company that fits the U.S. Interest Rate Sensitive Growth Stocks theme because it sells long duration, subscription based CX and AI tools whose valuation can respond quickly to changes in discount rate expectations. It generates all of its roughly US$1.2b in revenue from internet software and services, delivered as a SaaS platform to customers across sectors such as banking, healthcare and retail, and has a market cap of about US$2.4b.
Investors looking at Five9 today are getting a pure play on AI powered customer experience software at a time when lower rate expectations can matter a lot for long term cash flows. Recent quarters featured strong earnings, growing AI bookings, index inclusion and large multi year deals that support the long duration story. However, the company still carries execution and financing risk, a relatively new leadership bench and a one off loss that clouds headline profit numbers. For readers who want to understand whether those rate sensitive growth drivers outweigh the governance and funding questions, the details behind Five9’s AI momentum, recurring revenue mix and external funding reliance are where the real debate starts.
Five9’s AI story and long term SaaS contracts are getting attention, but the real swing factor is how growth expectations line up with discount rates. Get the full picture in the analyst forecasts for Five9
Teradyne is a US$69.3b test and robotics company that fits the U.S. Interest-Rate-Sensitive Growth Stocks theme because its semiconductor and automation customers rely on large, often debt financed capex plans that can react quickly to changing discount rates. Most of Teradyne’s revenue comes from Semiconductor Test at about US$3.7b, with smaller but meaningful contributions from Product Test at roughly US$386 million and Robotics at about US$356 million. That scale, together with its focus on AI related semiconductor testing and factory automation, makes Teradyne a stock investors may want to watch closely as Fed expectations shift.
Teradyne gives you direct exposure to AI driven semiconductor and factory automation spending at a time when earnings forecasts, capex plans and a new US$1.0b credit facility all tie the story closely to where rates settle. The company is leaning into AI test and robotics, supported by higher margins and an active buyback, yet also carries a rich valuation and full reliance on external funding that could bite if financing costs rise again. If you want to understand whether that mix of growth, rate sensitivity and execution risk is priced fairly, Teradyne’s deeper narrative is where the most important questions start.
Teradyne’s AI test and robotics story is accelerating, yet the market may not be pricing how closely its growth, margins and new US$1.0b credit line all tie together. Get the missing context in the analysis report for Teradyne
Fresh breakout stories rarely stay under the radar for long. Use this window while it matters, before prices get caught flying or dropping away. Act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com